Purpose

This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 75 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age 18 to 75 years old. - Have received a clinical diagnosis of post-acute sequelae of SARS-CoV-2 (PASC)/long COVID syndrome using the criteria specified by Thaweethai, et al., 2023 (JAMA). This symptom checklist provides a score based on the number and severity of symptoms. An individual with a score >12 is classified as having PASC. - Currently experiencing Fatigue/Brain Fog as assessed with the Post-COVID symptom checklist and the PedsQL questionnaire.

Exclusion Criteria

  • Neurological disorders including, but not limited to, stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease, or any other neuromuscular disease (self-report). - Diagnosed history of severe psychiatric diseases such as depression and schizophrenia (self-report). - Congestive heart failure. - Peripheral artery disease with claudication. - Cancer. - Pulmonary or renal failure. - Unstable angina. - Uncontrolled hypertension (more than 190/110 mmHg). - Severe aphasia. - Orthopedic or pain conditions. - Have had exposure to metal or metal implants, due to the hazardous effects of the magnetic field. - If on immunomodulatory therapy, they must have been on that therapy for at least 6 months before the start of the study. Healthy age- and sex-matched controls for PASC - Exclusion criteria: Participants with a history of any of the following will be excluded from the study: - Hospitalization due to SARS-CoV-2 infection. - Neurological disorders including, but not limited to, stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease, or any other neuromuscular disease (self-report). - Diagnosed history of severe psychiatric diseases such as depression and schizophrenia (self-report). - Congestive heart failure. - Peripheral artery disease with claudication.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Non-Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
PASC Participants - Physical Fatigue Task
Participants will perform a physically demanding task (grip force exertion task) repeatedly to induce physical fatigue.
  • Behavioral: Physical Fatigue
    Participants will perform a physically demanding task (grip force exertion task) repeatedly to induce physical fatigue.
Experimental
Control Participants - Physical Fatigue Task
Participants will perform a physically demanding task (grip force exertion task) repeatedly to induce physical fatigue.
  • Behavioral: Physical Fatigue
    Participants will perform a physically demanding task (grip force exertion task) repeatedly to induce physical fatigue.

Recruiting Locations

Kennedy Krieger Institute
Baltimore 4347778, Maryland 4361885 21201
Contact:
Anthony Gonzalez
443-923-2716
gonzalezan@kennedykrieger.org

More Details

Status
Recruiting
Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Study Contact

Anthony Gonzalez
443-923-2716
gonzalezan@kennedykrieger.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.